Johanna Friedl-Naderer insider trades

Open-market stock purchases and sales by Johanna Friedl-Naderer, Chief Commercial Officer at Dyne Therapeutics, Inc, from SEC Form 4 filings since Mar 2, 2022.

Recent trades

DateStockTradeValue
Sep 8, 2026DYN Dyne Therapeutics, IncSold$3.5K
Sep 4, 2026DYN Dyne Therapeutics, IncSold$21.9K
Aug 13, 2026DYN Dyne Therapeutics, IncSold$5.9K
Jun 16, 2026DYN Dyne Therapeutics, IncSold$2.7K
May 13, 2026DYN Dyne Therapeutics, IncSold$4.2K
Mar 5, 2026DYN Dyne Therapeutics, IncSold$2.2K
Feb 12, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Feb 12, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Dec 5, 2025DYN Dyne Therapeutics, IncSold$3K

Companies traded

  • DYN Dyne Therapeutics, Inc: 11 sales, last Sep 8, 2026
  • VIR Vir Biotechnology, Inc: 1 sale, last Mar 3, 2023

Get free alerts when Johanna Friedl-Naderer files a new trade →